<VariationArchive VariationID="143380" VariationName="NM_001110792.2(MECP2):c.1195_1210del (p.Pro399fs)" VariationType="Deletion" Accession="VCV000143380" Version="5" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-05-08" DateCreated="2014-08-17" MostRecentSubmission="2024-05-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="153112" VariationID="143380">
      <GeneList>
        <Gene Symbol="MECP2" FullName="methyl-CpG binding protein 2" GeneID="4204" HGNC_ID="HGNC:6990" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154021573" stop="154097717" display_start="154021573" display_stop="154097717" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153287263" stop="153363187" display_start="153287263" display_stop="153363187" Strand="-" />
          </Location>
          <OMIM>300005</OMIM>
          <Haploinsufficiency last_evaluated="2021-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MECP2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MECP2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001110792.2(MECP2):c.1195_1210del (p.Pro399fs)</Name>
      <CanonicalSPDI>NC_000023.11:154030653:CAGGTGGAGGTGGGGGCAGG:CAGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154030654" stop="154030669" display_start="154030654" display_stop="154030669" variantLength="16" positionVCF="154030653" referenceAlleleVCF="TCAGGTGGAGGTGGGGG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153296105" stop="153296120" display_start="153296105" display_stop="153296120" variantLength="16" positionVCF="153296104" referenceAlleleVCF="TCAGGTGGAGGTGGGGG" alternateAlleleVCF="T" />
      </Location>
      <OtherNameList>
        <Name>NM_001110792.2(MECP2):c.1195_1210del</Name>
        <Name>p.Pro399fs</Name>
      </OtherNameList>
      <ProteinChange>P294fs</ProteinChange>
      <ProteinChange>P399fs</ProteinChange>
      <ProteinChange>P387fs</ProteinChange>
      <ProteinChange>P164fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004992.3" sequenceAccession="NM_004992" sequenceVersion="3" change="c.1159_1174delCCCCCACCTCCACCTG">
            <Expression>NM_004992.3:c.1159_1174delCCCCCACCTCCACCTG</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.153296109_153296124del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.153296109_153296124del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.154030658_154030673del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.154030658_154030673del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007107.3" sequenceAccession="NG_007107" sequenceVersion="3" change="g.111435_111450del">
            <Expression>NG_007107.3:g.111435_111450del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001110792.2" sequenceAccession="NM_001110792" sequenceVersion="2" change="c.1195_1210del" MANESelect="true">
            <Expression>NM_001110792.2:c.1195_1210del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001104262.1" sequenceAccession="NP_001104262" sequenceVersion="1" change="p.Pro399fs">
            <Expression>NP_001104262.1:p.Pro399fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001316337.2" sequenceAccession="NM_001316337" sequenceVersion="2" change="c.880_895del">
            <Expression>NM_001316337.2:c.880_895del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001303266.1" sequenceAccession="NP_001303266" sequenceVersion="1" change="p.Pro294fs">
            <Expression>NP_001303266.1:p.Pro294fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369391.2" sequenceAccession="NM_001369391" sequenceVersion="2" change="c.880_895del">
            <Expression>NM_001369391.2:c.880_895del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356320.1" sequenceAccession="NP_001356320" sequenceVersion="1" change="p.Pro294fs">
            <Expression>NP_001356320.1:p.Pro294fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369392.2" sequenceAccession="NM_001369392" sequenceVersion="2" change="c.880_895del">
            <Expression>NM_001369392.2:c.880_895del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356321.1" sequenceAccession="NP_001356321" sequenceVersion="1" change="p.Pro294fs">
            <Expression>NP_001356321.1:p.Pro294fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369393.2" sequenceAccession="NM_001369393" sequenceVersion="2" change="c.880_895del">
            <Expression>NM_001369393.2:c.880_895del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356322.1" sequenceAccession="NP_001356322" sequenceVersion="1" change="p.Pro294fs">
            <Expression>NP_001356322.1:p.Pro294fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369394.2" sequenceAccession="NM_001369394" sequenceVersion="2" change="c.880_895del">
            <Expression>NM_001369394.2:c.880_895del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356323.1" sequenceAccession="NP_001356323" sequenceVersion="1" change="p.Pro294fs">
            <Expression>NP_001356323.1:p.Pro294fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386137.1" sequenceAccession="NM_001386137" sequenceVersion="1" change="c.490_505del">
            <Expression>NM_001386137.1:c.490_505del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001373066.1" sequenceAccession="NP_001373066" sequenceVersion="1" change="p.Pro164fs">
            <Expression>NP_001373066.1:p.Pro164fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386138.1" sequenceAccession="NM_001386138" sequenceVersion="1" change="c.490_505del">
            <Expression>NM_001386138.1:c.490_505del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001373067.1" sequenceAccession="NP_001373067" sequenceVersion="1" change="p.Pro164fs">
            <Expression>NP_001373067.1:p.Pro164fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386139.1" sequenceAccession="NM_001386139" sequenceVersion="1" change="c.490_505del">
            <Expression>NM_001386139.1:c.490_505del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001373068.1" sequenceAccession="NP_001373068" sequenceVersion="1" change="p.Pro164fs">
            <Expression>NP_001373068.1:p.Pro164fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004992.4" sequenceAccession="NM_004992" sequenceVersion="4" change="c.1159_1174del" MANEPlusClinical="true">
            <Expression>NM_004992.4:c.1159_1174del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004983.1" sequenceAccession="NP_004983" sequenceVersion="1" change="p.Pro387fs">
            <Expression>NP_004983.1:p.Pro387fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_764" sequenceAccession="LRG_764">
            <Expression>LRG_764:g.111435_111450del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_764t1" sequenceAccession="LRG_764t1">
            <Expression>LRG_764t1:c.1195_1210del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_764p1" sequenceAccession="LRG_764p1" change="p.Pro399fs">
            <Expression>LRG_764p1:p.Pro399fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_764t2" sequenceAccession="LRG_764t2">
            <Expression>LRG_764t2:c.1159_1174del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_764p2" sequenceAccession="LRG_764p2" change="p.Pro387fs">
            <Expression>LRG_764p2:p.Pro387fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="AJ132917.1" sequenceAccession="AJ132917" sequenceVersion="1" change="c.1159_1174del16">
            <Expression>AJ132917.1:c.1159_1174del16</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004992.3" sequenceAccession="NM_004992" sequenceVersion="3" change="c.1159_1174del16">
            <Expression>NM_004992.3:c.1159_1174del16</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA232906" DB="ClinGen" />
        <XRef Type="rs" ID="267608373" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001110792.2(MECP2):c.1195_1210del (p.Pro399fs) AND not provided" Accession="RCV000132905" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-08-18" SubmissionCount="2">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001110792.2(MECP2):c.1195_1210del (p.Pro399fs) AND Severe neonatal-onset encephalopathy with microcephaly" Accession="RCV002514762" Version="2">
        <ClassifiedConditionList TraitSetID="6528">
          <ClassifiedCondition DB="MedGen" ID="C1968556">Severe neonatal-onset encephalopathy with microcephaly</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001110792.2(MECP2):c.1195_1210del (p.Pro399fs) AND Rett syndrome" Accession="RCV004527339" Version="1">
        <ClassifiedConditionList TraitSetID="3215">
          <ClassifiedCondition DB="MedGen" ID="C0035372">Rett syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-04-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-04-22" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2014-08-17" MostRecentSubmission="2024-05-07">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19914908</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/38d2c45e-d3d6-4698-a210-7a563444dedb</URL>
        </Citation>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2017-12-19">
          <Description>not provided</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3215" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3622" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Rett syndrome</ElementValue>
                <XRef ID="MONDO:0010726" DB="MONDO" />
                <XRef ID="778" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Autism, dementia, ataxia, and loss of purposeful hand use</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Rett's disorder</ElementValue>
                <XRef ID="Rett+syndrome/6294" DB="Genetic Alliance" />
                <XRef ID="68618008" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">RTS</ElementValue>
                <XRef Type="MIM" ID="312750" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">RTT</ElementValue>
                <XRef Type="MIM" ID="312750" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">MECP2-Related Disorders</Attribute>
                <XRef ID="NBK1497" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5696" />
                <XRef ID="5696" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of MECP2-related phenotypes in females ranges from classic Rett syndrome to variant Rett syndrome with a broader clinical phenotype (either milder or more severe than classic Rett syndrome) to mild learning disabilities; the spectrum in males ranges from severe neonatal encephalopathy to pyramidal signs, parkinsonism, and macroorchidism (PPM-X) syndrome to severe syndromic/nonsyndromic intellectual disability. Females: Classic Rett syndrome, a progressive neurodevelopmental disorder primarily affecting girls, is characterized by apparently normal psychomotor development during the first six to 18 months of life, followed by a short period of developmental stagnation, then rapid regression in language and motor skills, followed by long-term stability. During the phase of rapid regression, repetitive, stereotypic hand movements replace purposeful hand use. Additional findings include fits of screaming and inconsolable crying, autistic features, panic-like attacks, bruxism, episodic apnea and/or hyperpnea, gait ataxia and apraxia, tremors, seizures, and acquired microcephaly. Males: Severe neonatal-onset encephalopathy, the most common phenotype in affected males, is characterized by a relentless clinical course that follows a metabolic-degenerative type of pattern, abnormal tone, involuntary movements, severe seizures, and breathing abnormalities. Death often occurs before age two years.</Attribute>
                <XRef ID="NBK1497" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301670</ID>
                <ID Source="BookShelf">NBK1497</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="pmc">3111012</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23519317</ID>
              </Citation>
              <XRef ID="3095" DB="Orphanet" />
              <XRef ID="778" DB="Orphanet" />
              <XRef ID="C0035372" DB="MedGen" />
              <XRef ID="MONDO:0010726" DB="MONDO" />
              <XRef Type="MIM" ID="312750" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6528" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1150" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Encephalopathy, neonatal severe, due to MECP2 mutations</ElementValue>
                <XRef ID="Encephalopathy%2C+neonatal+severe%2C+due+to+MECP2+mutations/8310" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Encephalopathy, neonatal severe</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Severe neonatal-onset encephalopathy with microcephaly</ElementValue>
                <XRef ID="MONDO:0010397" DB="MONDO" />
                <XRef ID="209370" DB="Orphanet" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">MECP2-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="Genetics Home Reference (GHR) links">MECP2-related severe neonatal encephalopathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17103" />
                <XRef ID="17103" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">MECP2-Related Severe Neonatal Encephalopathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of MECP2-related phenotypes in females ranges from classic Rett syndrome to variant Rett syndrome with a broader clinical phenotype (either milder or more severe than classic Rett syndrome) to mild learning disabilities; the spectrum in males ranges from severe neonatal encephalopathy to pyramidal signs, parkinsonism, and macroorchidism (PPM-X) syndrome to severe syndromic/nonsyndromic intellectual disability. Females: Classic Rett syndrome, a progressive neurodevelopmental disorder primarily affecting girls, is characterized by apparently normal psychomotor development during the first six to 18 months of life, followed by a short period of developmental stagnation, then rapid regression in language and motor skills, followed by long-term stability. During the phase of rapid regression, repetitive, stereotypic hand movements replace purposeful hand use. Additional findings include fits of screaming and inconsolable crying, autistic features, panic-like attacks, bruxism, episodic apnea and/or hyperpnea, gait ataxia and apraxia, tremors, seizures, and acquired microcephaly. Males: Severe neonatal-onset encephalopathy, the most common phenotype in affected males, is characterized by a relentless clinical course that follows a metabolic-degenerative type of pattern, abnormal tone, involuntary movements, severe seizures, and breathing abnormalities. Death often occurs before age two years.</Attribute>
                <XRef ID="NBK1497" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301670</ID>
                <ID Source="BookShelf">NBK1497</ID>
              </Citation>
              <XRef ID="209370" DB="Orphanet" />
              <XRef ID="C1968556" DB="MedGen" />
              <XRef ID="MONDO:0010397" DB="MONDO" />
              <XRef Type="MIM" ID="300673" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="310686" SubmissionDate="2012-08-08" DateLastUpdated="2014-08-17" DateCreated="2014-08-17">
        <ClinVarSubmissionID localKey="1159_1174del16" />
        <ClinVarAccession Accession="SCV000187886" DateUpdated="2014-08-17" DateCreated="2014-08-17" Type="SCV" Version="1" SubmitterName="RettBASE" OrgID="504290" OrganizationCategory="locus-specific database (LSDB)" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">AJ132917.1:c.1159_1174del16</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>CHWRETT_2012_1_30</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1203822" SubmissionDate="2019-01-29" DateLastUpdated="2017-12-19" DateCreated="2017-12-19">
        <ClinVarSubmissionID localKey="GDX:675474|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000617414" DateUpdated="2017-12-19" DateCreated="2017-12-19" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-08-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The c.1159_1174del16 variant in the MECP2 gene has been reported previously (reported as c.1155_1170del due to alternative nomenclature) in a French individual who had MECP2 testing; however the c.1205+1432del228 variant was also detected in the same individual (Philippe et al., 2006). The c.1159_1174del16 variant causes a frameshift starting with codon Proline 387, changes this amino acid to a Serine residue, and creates a premature Stop codon at position 17 of the new reading frame, denoted p.Pro387SerfsX17. This variant is predicted to cause loss of normal protein function through protein truncation. The c.1159_1174del16 variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret c.1159_1174del16 as a likely pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MECP2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004992.3:c.1159_1174del16</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6133958" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4982962|MedGen:C1968556" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003445864" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19914908</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Pro387Serfs*17) in the MECP2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 100 amino acid(s) of the MECP2 protein. For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the MECP2 protein in which other variant(s) (p.Tyr450Leufs*37) have been determined to be pathogenic (PMID: 19914908). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 143380). This variant has not been reported in the literature in individuals affected with MECP2-related conditions. This variant is not present in population databases (gnomAD no frequency).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MECP2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.153296105_153296120del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1968556" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9758117" SubmissionDate="2024-05-03" DateLastUpdated="2024-05-07" DateCreated="2024-05-07">
        <ClinVarSubmissionID localKey="38d2c45e-d3d6-4698-a210-7a563444dedb" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV005040716" DateUpdated="2024-05-07" DateCreated="2024-05-07" Type="SCV" Version="1" SubmitterName="Centre for Population Genomics, CPG" OrgID="509293" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-04-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/38d2c45e-d3d6-4698-a210-7a563444dedb</URL>
          </Citation>
          <Comment>This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as pathogenic. At least the following criteria are met: Predicted to result in loss of function, and LOF is a known mechanism of disease (PVS1). This variant is absent from gnomAD v3 (PM2_Supporting). Has been observed in at least 2 individuals with phenotypes consistent with MECP2-related disease (PS4_Supporting). PMID 16473305, ClinVar Variation ID: 143380</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">McKnight et al. (Hum Mutat. 2022)</Attribute>
          <Citation>
            <ID Source="PubMed">34837432</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MECP2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_001110792.2(MECP2):c.1195_1210del</Name>
            <Name>p.Pro399fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.11:g.154030658_154030673del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0010726" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14423027</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6133958" TraitType="Disease" MappingType="XRef" MappingValue="C1968556" MappingRef="MedGen">
        <MedGen CUI="C1968556" Name="Severe neonatal-onset encephalopathy with microcephaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1203822" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9758117" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0010726" MappingRef="MONDO">
        <MedGen CUI="C0035372" Name="Rett syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="310686" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

